Navigating the Transition: A Scoping Review of System-Level Factors in Biosimilar Integration for Immune-Mediated Inflammatory Diseases
Multiple components of the healthcare system play a role in successful biosimilar transitions. Leveraging regulations, policies, infrastructure, and communication before, during, and after transition offers a practical blueprint for managing brand changes across health systems and therapies.
Authors
- Chiara Gasteiger (ORCID: https://orcid.org/0000-0002-0597-2349)
- Nicola Dalbeth
- Shania Kumar
Institutions
- University of Auckland (NZ)
- Health Research Council of New Zealand (NZ)
- Auckland University of Technology (NZ)
Publication Details
- Journal
- BioDrugs
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1007/s40259-026-00765-1
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Arthritis New Zealand